Loading…
Sectoral / Thematic · UTI Mutual Fund · AMFI code 100806UTI - Healthcare Fund
Disclosed for 95 months, Jul 2017 to Sep 2026.
Portfolio value
₹721 Cr
down ₹4.8 Cr vs Oct 2022
- Stocks held
- 32
- up 1 vs Oct 2022
- Top 10 weight
- 58.9%
- of the portfolio in its ten largest
- Cash & debt
- 1.5%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 15
UTI - Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In November 2022 it disclosed 32 stocks worth ₹721 Cr, down ₹4.8 Cr from Oct 2022. Its largest positions were Sun Pharmaceutical Industries Limited (13.6%), Cipla Limited (9.0%), Dr. Reddy's Laboratories Limited (6.8%); the ten largest together made up 58.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 77.7% of its equity. Cash and debt stood at 1.5%. Compared with Oct 2022 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
81%
Top-10 weight is higher than 81% of peers
Breadth
18%
Holds more stocks than 18% of peers
Cash
23%
Holds more cash than 23% of peers
Holdings in November 2022
Download CSVEvery line the fund disclosed, with the change against Oct 2022. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.61%
- Δ weight
- up 0.59 pts
- Value
- ₹98.1 Cr
- Δ value
- up ₹3.7 Cr
- Status
- Added
- Weight
- 9.00%
- Δ weight
- down 0.34 pts
- Value
- ₹64.8 Cr
- Δ value
- down ₹2.9 Cr
- Status
- Trimmed
- Weight
- 6.76%
- Δ weight
- down 0.51 pts
- Value
- ₹48.7 Cr
- Δ value
- down ₹4 Cr
- Status
- Trimmed
- Weight
- 6.56%
- Δ weight
- up 0.73 pts
- Value
- ₹47.3 Cr
- Δ value
- up ₹5 Cr
- Status
- Added
- Weight
- 4.56%
- Δ weight
- up 0.23 pts
- Value
- ₹32.8 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 3.81%
- Δ weight
- up 0.06 pts
- Value
- ₹27.5 Cr
- Δ value
- up ₹22 L
- Status
- Added
- Weight
- 3.73%
- Δ weight
- down 0.18 pts
- Value
- ₹26.9 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 3.65%
- Δ weight
- down 0.17 pts
- Value
- ₹26.3 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 3.63%
- Δ weight
- down 0.69 pts
- Value
- ₹26.2 Cr
- Δ value
- down ₹5.2 Cr
- Status
- Trimmed
- Weight
- 3.61%
- Δ weight
- up 0.17 pts
- Value
- ₹26 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 3.55%
- Δ weight
- down 0.18 pts
- Value
- ₹25.5 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 3.54%
- Δ weight
- down 0.73 pts
- Value
- ₹25.5 Cr
- Δ value
- down ₹5.5 Cr
- Status
- Trimmed
- Weight
- 3.29%
- Δ weight
- up 0.49 pts
- Value
- ₹23.7 Cr
- Δ value
- up ₹3.4 Cr
- Status
- Added
- Weight
- 3.19%
- Δ weight
- up 0.04 pts
- Value
- ₹23 Cr
- Δ value
- up ₹14 L
- Status
- Added
- Weight
- 2.47%
- Δ weight
- up 0.18 pts
- Value
- ₹17.8 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Weight
- 2.26%
- Δ weight
- up 0.13 pts
- Value
- ₹16.3 Cr
- Δ value
- up ₹80 L
- Status
- Added
- Weight
- 2.16%
- Δ weight
- down 0.27 pts
- Value
- ₹15.6 Cr
- Δ value
- down ₹2 Cr
- Status
- Trimmed
- Weight
- 2.02%
- Δ weight
- up 0.19 pts
- Value
- ₹14.5 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 2.02%
- Δ weight
- down 0.04 pts
- Value
- ₹14.5 Cr
- Δ value
- down ₹42 L
- Status
- Trimmed
- Weight
- 1.79%
- Δ weight
- up 0.11 pts
- Value
- ₹12.9 Cr
- Δ value
- up ₹74 L
- Status
- Added
- Weight
- 1.64%
- Δ weight
- up 0.09 pts
- Value
- ₹11.8 Cr
- Δ value
- up ₹54 L
- Status
- Added
- Weight
- 1.60%
- Δ weight
- up 0.06 pts
- Value
- ₹11.5 Cr
- Δ value
- up ₹36 L
- Status
- Added
- Weight
- 1.59%
- Δ weight
- up 0.12 pts
- Value
- ₹11.5 Cr
- Δ value
- up ₹77 L
- Status
- Added
- Weight
- 1.34%
- Δ weight
- down 0.01 pts
- Value
- ₹9.7 Cr
- Δ value
- down ₹11 L
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.32%
- Δ weight
- down 0.49 pts
- Value
- ₹9.5 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 1.28%
- Δ weight
- up 0.35 pts
- Value
- ₹9.2 Cr
- Δ value
- up ₹2.5 Cr
- Status
- Added
- Weight
- 1.12%
- Δ weight
- down 0.16 pts
- Value
- ₹8 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 1.00%
- Δ weight
- up 0.44 pts
- Value
- ₹7.2 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Weight
- 0.99%
- Δ weight
- down 0.31 pts
- Value
- ₹7.1 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
- Weight
- 0.83%
- Δ weight
- down 0.09 pts
- Value
- ₹5.9 Cr
- Δ value
- down ₹66 L
- Status
- Trimmed
- Weight
- 0.77%
- Δ weight
- down 0.06 pts
- Value
- ₹5.5 Cr
- Δ value
- down ₹48 L
- Status
- Trimmed
- Weight
- 0.62%
- Δ weight
- down 0.25 pts
- Value
- ₹4.5 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Weight
- 0.53%
- Δ weight
- up 0.53 pts
- Value
- ₹3.8 Cr
- Δ value
- up ₹3.8 Cr
- Status
- New
- 364 D TBILL MATDebt
- Weight
- 0.17%
- Δ weight
- up <0.01 pts
- Value
- ₹1.3 Cr
- Δ value
- up ₹1 L
- Status
- Added
What changed, Oct 2022 to Nov 2022
New New positions (1)
- Sanofi India Limited0.5% · ₹3.8 Cr
Exited Exited (0)
None.
Added Biggest additions
- Apollo Hospitals Enterprise Limitedup ₹5 Cr (+0.73% pts)
- Sun Pharmaceutical Industries Limitedup ₹3.7 Cr (+0.59% pts)
- Suven Pharmaceuticals Limitedup ₹3.4 Cr (+0.49% pts)
- WINDLAS BIOTEC LTDup ₹3.1 Cr (+0.44% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Oct 2022, the weight rose most in Healthcare Services (+0.9 pts) and Pharmaceuticals (+0.3 pts), and fell most in Pharmaceuticals & Biotechnology (−1.3 pts).
- Healthcare Services18.3% → 19.2%+0.9 pts
- Pharmaceuticals1.0% → 1.3%+0.3 pts
- Healthcare Equipment & Supplies1.7% → 1.8%+0.1 pts
- Pharmaceuticals & Biotechnology79.0% → 77.7%−1.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2019 | Nov 2021 | May 2022 | Jul 2022 | Oct 2022 | Nov 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 90.8% | 78.9% | 79.9% | 79.8% | 79.0% | 77.7% |
| Healthcare Services | 9.2% | 17.5% | 17.0% | 17.1% | 18.3% | 19.2% |
| Healthcare Equipment & Supplies | — | 1.9% | 1.6% | 1.6% | 1.7% | 1.8% |
| Pharmaceuticals | — | — | 0.3% | 0.7% | 1.0% | 1.3% |
Allocation in Nov 2022change vs Oct 2022
- Pharmaceuticals & Biotechnology (24)77.7%▼ 1.3 pts
- Healthcare Services (6)19.2%▲ 0.9 pts
- Healthcare Equipment & Supplies (1)1.8%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Nov 2022
1.5%
▼ 0.5 pts vs Oct 2022
- Cash alone
- 1.3%
- cash and net receivables
- A year earlier
- 2.5%
- Nov 2021 · now ▼ 1.0 pts
- Last 12 months
- 1.4% – 3.3%
- lowest to highest · record 7.3% in Jul 2017
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.